GA HR1794

Urges the Georgia Commissioner of Insurance to conduct a comprehensive review of prescription drug pricing and identify strategies to reduce medication costs for Georgia citizens.

Calls for examination of pharmaceutical supply chain transparency, including the roles of manufacturers, pharmacy benefits managers, and insurers in driving costs.

Requires a report of findings and recommendations to be submitted to the Governor, President of the Senate, and Speaker of the House of Representatives.

Cites rising prescription drug prices as causing financial burden on patients, families, employers, and public health programs, while leading to decreased medication adherence and worsened health outcomes.